'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations
Crossref DOI link: https://doi.org/10.1038/ni.3682
Published Online: 2017-03-01
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tran, Eric
Robbins, Paul F
Rosenberg, Steven A
Text and Data Mining valid from 2017-03-01
Article History
Received: 15 November 2016
Accepted: 6 January 2017
First Online: 1 March 2017
Competing interests
: The authors declare no competing financial interests.